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Expression of mRNAs encoding hexokinase isozymes was studied in various cells such as rat brain. liver, skeletal muscle, kidney and heart, and 
the rat hepatoma cell line AH130 by Northern blotting. High specific expression of type ?I hexokinase was observed only with AH130 cells. In 
contrast. specific expression of type 1 hexokinase was detected in energy-requiring normal tissue cells such as brain and heart. These results suggest 
that the expression of hexokinase isozyme in the tumor cells is different from that in normal cells. 
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1. INTRODUCTION 
Hexokinase (EC 2.7.1. l), a key enzyme in glycolysis, 
catalyzes the conversion of gIucose to glucose-6-phos- 
phate. Therefore, the activity of hexokinase is high in 
tissues in which efficient energy conversion is required: 
the activity in brain is about IO-fold that of other tissues 
[1,2]. As the activity in tumor cells such as AS-30D is 
extremely high being more than lOO-fold that in normal 
cells [2,3], much attention has been paid to its induction 
in tumor cells. 
line AH130 by Northern analysis of their mRNAs. We 
found that type I hexokinase is significantly expressed 
in normal energy requiring cells such as brain and heart 
cells, and that the type II enzyme is highly expressed in 
hepatoma AH130 cells. In contrast, no significant ex- 
pression of type II hexokinase was observed in any of 
these cells. 
2. MATERIALS AND METHODS 
There are three types of hexokinase isozymes, types 
I, II and III, and cDNAs encoding these isozymes have 
been cloned from cDNA libraries of rat brain [4,5] and 
human kidney [6], rat skeletal muscle [7], and rat liver 
[g], respectively. The homologies of these isozymes are 
very high and they all consist of two identical chains 
with a molecular mass of about 100 kDa. Glucokinase 
(EC 2.7.1.2), which has half the molecular mass of hexo- 
kinase and which consists of a single peptide chain of 
half the duplicated sequence of hexokinase, is sorne- 
times called type IV hexokinase. To understand the de- 
tailed mechanism of energy conversion in relation to the 
activity of hexokinase, especially in tumor cells, it is 
important to know whether the expression of hexoki- 
nase isozymes is tissue specific and if so, which isozyme 
is responsible for its high activity for efficient energy 
conversion. 
[cl-‘2P]dCTP (I 11 TBq/mmol) was obtained from New England 
Nuclear. Nitrocellulose membrane (BA85) was purchased from 
Schleicher & Schuell. Other materials and reagents were of the highest 
grade commercially available. 
Total RNA was purified from rat hepatoma AH130 and liver, 
kidney, hoart, skeletal and brain of male Wistar rat by the guanidium 
thiocyanate method [9], 
Specific molecular probes for each of the three isozymes were 
designed carefully to avoid cross-hybridization witt other isozymes as 
shown in Table I. These probes were radiolabelled with [cw-“‘PJdCfP 
by the specific priming method [9]. The spccilic radioactivities of these 
probes wcrc more than 10” cpmlpg. 
As a first step in the study of this problem, we deter- 
mined the types of hexokinase isozymes expressed in 
various tissue cells of rats such as liver, kidney, skeletal 
muscle, heart, and brain, and in the rat hepatoma cell 
Total RNAs were obtained from various tissue cells and thcAHl30 
cell line, and samples of 8.0 pug were separated by electrophorcsis in 
formaldehyde containing gel and transferred to a nitrocellulose mem. 
brane. Hybridization was carried at 42°C in the presence of 50% of 
formamide and then the Inembrane was washed with a solution of 300 
mM NaCl and 30 mM sodium citrate, pH 7,O (2 x SSC) containing 
0.1% SDS for IO tnin at room tcmpcraturc, This treatment was rc- 
peated 3 times, and then themcmbranc was washed once with the same 
solution at 60°C for 40 min, Hybridization bands were visualized 
autoradiographically by exposing the filter membrane to X-ray film 
at -80°C for 3 days with aa intensifying screen After autoradio. 
grnphy, the amount of the RNA loaded was confirmed by staining 
with mcthylcne blue (9). 
Gcr~rc.r/~o,lcltIrrc’P iic/c/rcl,r,r: HI TCl2dil. FXUlly Of Phill~l~lilCeUtiCal S&n- 
ccs, University of TokUshitna, ShomUchi-I, TokUshima 770. Japan. 
Fax: (HI) (866) 33 0510. 
3. RESULTS AND DISCUSSION 
We isolated total RNAs from various tissue cells of 
rats such as the liver, kidney, skeletal muscle, heart and 
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Fig. 1. Northern hybridization of total RNAs isolated feom vaeious rat tissues and the rat hepatoma AI-II 30 cell line. After transfer to nitrocellulose 
membranes, RNAs were hybridized with probe I (A), II (B) and III (C). (Lane 1) liver; (lane 2) hepatoma AH 130; (lane 3) kidney; (lane 4) heart; 
(lane 5) skeletal muscle: (lane 6) braip cells. The positions of 28 S and 18 S ribosomal RNAs are shown by arrows. 
brain, and the rat hepatoma cell line AH 130, and exam- 
ined which hexokinase isoform is expressed in these 
cells. Based on the reported sequences ofcDWAs for the 
three hexokinase isozymes [4-g], we synthesized three 
sets of oligonucleotides, referred to as probe I, II and 
III, as molecular probes for type I, II and III he- 
xokinase, respectively (cf. Materials and Methods and 
Table I). As shown in Fig. 1, the molecular prpbes for 
each isozyme did not cross-hybridize with the other two 
isozymes under the present hybridization and washing 
conditions (cf. Materials and Methods), indicating that 
they were suitable as specific probes for the three he- 
xokinase isozymes. 
On nitrocellulose membranes RNA samples from 
brain and heart gave strong hybridization bands with 
probe I (fig. IA). Expression of the type I isozyme was 
low in the kidney and hepatoma AH130, and was not 
detectable in the liver or skeletal muscle. In contrast, 
with probe II, AH130 cells gave two extremely strong 
bands of very similar molecular masses, while heart and 
skeletal muscle cells gave two faint bands. RNAs from 
other tissues such as liver, kidney and brain did not 
react with probe II (Fig. 1B). None of the significant 
bands of RNAs hybridized with probe III were ob- 
served (cf. Fig. 1C). 
There have been many reports of structural charac- 
terization of the three isozymes [4-8,10-14]. l3ut to the 
best of our knowledge the only paper on expression of 
hexokinase isozymes is the recent report by Thelen and 
Wilson [7] of the expression of type II hexokinase iso- 
zyme. They showed by Northern blotting, that type II 
hexokinase was expressed in both the Movikoff ascites 
tumor cell line and rat skeletal muscle cells, and they 
concluded that, contrary to expectation [3], there is no 
distinction between the isozymes in tumor and normal 
cells. I-Iowever, their conclusion was based on the simi- 
lar intensities of the hybridization bands of, the two 
types of cells, although they used about 7 times more 
mRNA from skeletal muscle cells than from Novikoff 
hepatoma cells [7]. Thus, contrary to their conclusion, 
Probe 
Table I 
Molecular probes for hexokinase isozymes 
Synthesized oligonucleotidcs” Corresponding position of cDNAb Reference 
5’ 3’ 
I AGAGGAGACCCTTCGATCGCCTAAAAGCCAGGA 1336-1368 5 
ATTTTCGGTCCT 
5' 3' 
II ATCCGGGAGGCTGGGCAGAGATAGAAGCTTGGG 2928-2960 1 
ATCTTCGAACCC 
3' 
111 ~GTCTGCACCCGGGAGAAAGAGACTCAAGTGC 102-134 8 
CTGAGTTCGACG 
-- 
nAll probes wcrc designed as 33mcrs und shown with their .q~cific primers (12.mers each). 
hPositions of the nuclcotide sequences are indicated according to those in the references cited, 
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their results indicate that the expression of type II hexo- 
kinase is about 7 times greater in the Novikoff hepa- 
toma cells than im skeletal muscle. 
As we used the same amounts of total RWAs in this 
study, the relative amounts of rnRNA of each isozyme 
expressed could be compared directly. Accordingly, our 
results show that the type I isozyme is expressed mainly 
in energy requiring normal tissues such as brain and 
heart, and type II hexokinase predominantly in tumor 
cells such as hepatorna AI-II30 cells, although slight 
expression of the type I isozyme was also observed in 
these tumor cells. Furthermore, no significant expres- 
sion of type III isozyme was observed under the present 
experimental conditions using total RNAs, suggesting 
that the expression of this type of isozyme was very low, 
although it should exist at least in the liver [g]. 
In the present study, we demonstrated for the first 
time the tissue specific expression of type I and II hexo- 
kinase isozymes in various tissue cells of rats and a rat 
derived hepatoma oell-line, and found that expression 
of hexokinase isozymes in tumor cells is distinct from 
that in normal cells. These findings are consistent with 
the results of Thelen and Wilson [7] on Novikoff ascites 
tumor cells. Information on the mechanism of regula- 
tion of type II hexokinase expression in tumor cells and 
that of type I hexokinase in brain and heart cells is 
important for understanding the mechanism of efficient 
energy conversion in tumor GelIs and how it differs from 
that in brain and heart cells. 
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